Allonge #1 to Convertible Promissory Note between Bionik Laboratories Corp. and Celeste Management

Summary

This agreement amends a previous $70,000 Convertible Promissory Note between Bionik Laboratories Corp. (the borrower) and Celeste Management (the lender). The main change is to the note's maturity date, which is now set as the earlier of June 30, 2020, or the completion of a qualified financing, but not before December 31, 2019. All other terms of the original note remain unchanged. The amendment is effective as of March 30, 2020.

EX-10.2 3 tm2014053d1_ex10-2.htm EXHIBIT 10.2

Exhibit 10.2

ALLONGE #1 TO CONVERTIBLE PROMISSORY NOTE

Allonge #1 (this “Allonge”) to that certain Convertible Promissory Note (the “Convertible Promissory Note”) attached hereto as Exhibit 1 and made a part hereof in the principal amount of $70,000 dated September 26, 2019 from Bionik Laboratories Corp., as Maker (“Maker”), to Celeste Management, as Holder (“Holder”).

Maker and Holder agree that the Convertible Promissory Note shall be revised as follows:

1. The definition of “Maturity Date” in Section 1.1 of the Convertible Promissory Note shall be amended and replaced to read as follows:

““Maturity Date” shall mean the earlier of: (a) June 30, 2020 and (b) the consummation of a Qualified Financing but in no event earlier than December 31, 2019.”

Except as expressly reflected herein, the Convertible Promissory Note will remain in full force and effect. This Allonge is intended to be attached to and made a permanent part of the Convertible Promissory Note.

Dated as of the 30^th day of March 2020.

Maker:	BIONIK LABORATORIES CORP.


	By:	/s/ Eric Dusseux
	Name:	Eric Dusseux
	Title:	CEO

Holder:	CELESTE MANAGEMENT


	By:	/s/ Dimitri Boulanger
	Name:	Dimitri Boulanger
	Title:	CEO

EXHIBIT A